» Articles » PMID: 18165172

Glucocorticoid Receptor Beta Splice Variant Expression in Patients with High and Low Activity of Systemic Lupus Erythematosus

Overview
Specialty Cell Biology
Date 2008 Jan 1
PMID 18165172
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The glucocorticoid receptor (GR) occurs mainly in two alternative splice variants encoding GRalpha and GRbeta. The GRbeta variant does not contain a GC binding domain and cannot mediate anti-inflammatory GC effects. Peripheral blood mononuclear cells (PBMCs) were isolated from venous whole blood of twelve patients with SLE. Ten of the SLE patients exhibited low disease activity while two patients displayed highly active stage of the disease. The quantitative analysis of GRalpha and GRbeta transcripts in PBMC was performed by reverse transcription and real-time quantitative PCR SYBR Green I system. The protein level of GRalpha and GRbeta isoforms in PBMCs was determined by western blotting analysis. We found that the two SLE patients with high disease activity exhibited significantly elevated GRbeta transcript levels and corresponding protein levels in PBMCs. These preliminary findings suggest that increased expression of GRbeta isoform may be associated with relatively more severe clinical presentation of SLE syndrome.

Citing Articles

Expression pattern of glucocorticoid receptor α gene and associations with clinicolaboratory features in patients with systemic lupus erythematosus.

Sahebari M, Rezaieyazdi Z, Khodashahi M, Rafatpanah H, Mehrad-Majd H, Saadati N Caspian J Intern Med. 2023; 14(3):470-478.

PMID: 37520872 PMC: 10379795. DOI: 10.22088/cjim.14.3.470.


Corticosteroid Treatment-Resistance in Myasthenia Gravis.

Kaminski H, Denk J Front Neurol. 2022; 13:886625.

PMID: 35547366 PMC: 9083070. DOI: 10.3389/fneur.2022.886625.


The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis.

Lonetti A, Indio V, Dianzani I, Ramenghi U, Da Costa L, Pospisilova D Front Physiol. 2021; 12:745032.

PMID: 34721069 PMC: 8549833. DOI: 10.3389/fphys.2021.745032.


Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?.

Flynn J, Dankers W, Morand E Front Immunol. 2019; 10:1684.

PMID: 31379872 PMC: 6652235. DOI: 10.3389/fimmu.2019.01684.


Glucocorticoids pharmacology and their application in the treatment of childhood-onset systemic lupus erythematosus.

Deng J, Chalhoub N, Sherwin C, Li C, Brunner H Semin Arthritis Rheum. 2019; 49(2):251-259.

PMID: 30987856 PMC: 6744986. DOI: 10.1016/j.semarthrit.2019.03.010.